The effect of continuing versus withholding angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers on mortality and major adverse cardiovascular events in hypertensive patients undergoing elective non-cardiac surgery: study protocol for a multi-centric open-label randomised controlled trial

BACKGROUND: Angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs) are commonly prescribed to patients with hypertension. These drugs are cardioprotective in addition to their blood pressure-lowering effects. However, it is debatable whether hypertensive patients who p...

Descripción completa

Detalles Bibliográficos
Autores principales: Misra, Satyajeet, Parida, Satyen, Sahajanandan, Raj, Behera, Bikram Kishore, Senthilnathan, Muthapillai, Mariappan, Ramamani, Chandy, Tony Thomson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386985/
https://www.ncbi.nlm.nih.gov/pubmed/35978368
http://dx.doi.org/10.1186/s13063-022-06616-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386985/
https://www.ncbi.nlm.nih.gov/pubmed/35978368
http://dx.doi.org/10.1186/s13063-022-06616-y

Ejemplares similares